AU2013205129B2 - Plasma kallikrein binding proteins - Google Patents
Plasma kallikrein binding proteinsInfo
- Publication number
- AU2013205129B2 AU2013205129B2 AU2013205129A AU2013205129A AU2013205129B2 AU 2013205129 B2 AU2013205129 B2 AU 2013205129B2 AU 2013205129 A AU2013205129 A AU 2013205129A AU 2013205129 A AU2013205129 A AU 2013205129A AU 2013205129 B2 AU2013205129 B2 AU 2013205129B2
- Authority
- AU
- Australia
- Prior art keywords
- binding proteins
- plasma kallikrein
- kallikrein binding
- proteins
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013205129A AU2013205129B2 (en) | 2010-01-06 | 2013-04-13 | Plasma kallikrein binding proteins |
| AU2016244213A AU2016244213B2 (en) | 2010-01-06 | 2016-10-11 | Plasma kallikrein binding proteins |
| AU2018253476A AU2018253476C1 (en) | 2010-01-06 | 2018-10-23 | Plasma kallikrein binding proteins |
| AU2019204295A AU2019204295B2 (en) | 2010-01-06 | 2019-06-19 | Plasma kallikrein binding proteins |
| AU2020204600A AU2020204600B2 (en) | 2010-01-06 | 2020-07-09 | Plasma kallikrein binding proteins |
| AU2023278128A AU2023278128A1 (en) | 2010-01-06 | 2023-12-11 | Plasma kallikrein binding proteins |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61/292,614 | 2010-01-06 | ||
| AU2011204349A AU2011204349C1 (en) | 2010-01-06 | 2011-01-06 | Plasma kallikrein binding proteins |
| AU2013205129A AU2013205129B2 (en) | 2010-01-06 | 2013-04-13 | Plasma kallikrein binding proteins |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011204349A Division AU2011204349C1 (en) | 2010-01-06 | 2011-01-06 | Plasma kallikrein binding proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016244213A Division AU2016244213B2 (en) | 2010-01-06 | 2016-10-11 | Plasma kallikrein binding proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2013205129A1 AU2013205129A1 (en) | 2013-05-16 |
| AU2013205129B2 true AU2013205129B2 (en) | 2016-07-14 |
Family
ID=48538150
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013205129A Active 2034-01-30 AU2013205129B2 (en) | 2010-01-06 | 2013-04-13 | Plasma kallikrein binding proteins |
| AU2023278128A Pending AU2023278128A1 (en) | 2010-01-06 | 2023-12-11 | Plasma kallikrein binding proteins |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023278128A Pending AU2023278128A1 (en) | 2010-01-06 | 2023-12-11 | Plasma kallikrein binding proteins |
Country Status (1)
| Country | Link |
|---|---|
| AU (2) | AU2013205129B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12487299B2 (en) | 2022-06-20 | 2025-12-02 | Shanghai United Imaging Healthcare Co., Ltd. | Magnetic resonance imaging devices and radiation therapy systems including the magnetic resonance imaging devices |
-
2013
- 2013-04-13 AU AU2013205129A patent/AU2013205129B2/en active Active
-
2023
- 2023-12-11 AU AU2023278128A patent/AU2023278128A1/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12487299B2 (en) | 2022-06-20 | 2025-12-02 | Shanghai United Imaging Healthcare Co., Ltd. | Magnetic resonance imaging devices and radiation therapy systems including the magnetic resonance imaging devices |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023278128A1 (en) | 2024-01-04 |
| AU2013205129A1 (en) | 2013-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125705T1 (en) | PLASMA KALLIKREIN BINDING PROTEINS | |
| EP2539473B8 (en) | Modified proteins and methods of making and using same | |
| EP4302783A3 (en) | Modified relaxin polypeptides and their uses | |
| EP2566890A4 (en) | Anti-pai-1 antibodies and methods of use thereof | |
| PH12013501339A1 (en) | Anti-pcsk9 antibodies and methods of use | |
| MX340555B (en) | Antibodies against il-18r1 and uses thereof. | |
| PH12014501427A1 (en) | Anti-php-tau antibodies and their uses | |
| EP4223770A3 (en) | Novel fusion molecules and uses thereof | |
| UA118328C2 (en) | Targeted gemomic alteration | |
| MX336001B (en) | Anti-axl antibodies and methods of use. | |
| MX2013015311A (en) | Pcsk9-binding polypeptides and methods of use. | |
| MX2014002053A (en) | Anti-mcsp antibodies. | |
| AU2011323828A8 (en) | Chromobacterium bioactive compositions and metabolites | |
| WO2013078217A3 (en) | Anti-microbial peptides and methods of use thereof | |
| MX2012011829A (en) | Anti-polyubiquitin antibodies and methods of use. | |
| EP2547782B8 (en) | Methods, kits and compositions for detection of mrsa | |
| PH12013500500A1 (en) | Fused heteroaryls and their uses | |
| WO2013163297A8 (en) | Modified glycoproteins | |
| WO2012078816A9 (en) | Proteins that efficiently generate singlet oxygen | |
| MX350452B (en) | Cooling and processing materials. | |
| EP2601316A4 (en) | Hide processing methods and compositions | |
| AU2013205129B2 (en) | Plasma kallikrein binding proteins | |
| MX2013005699A (en) | Stable preserved compositions if interferon-beta. | |
| WO2012091777A3 (en) | Complementary biasing circuits and related methods | |
| HK1192759A (en) | Plasma kallikrein binding proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| NC | Extension of term for standard patent requested (sect. 70) |
Free format text: PRODUCT NAME: TAKHZYRO LANADELUMAB Filing date: 20190130 |
|
| NDA | Extension of term for standard patent accepted (sect.70) |
Free format text: PRODUCT NAME: TAKHZYRO LANADELUMAB Filing date: 20190130 |
|
| NDB | Extension of term for standard patent granted (sect.76) |
Free format text: PRODUCT NAME: TAKHZYRO LANADELUMAB Filing date: 20190130 Extension date: 20340130 |
|
| DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ SEXTON, DANIEL J. AND VISWANATHAN, MALINI |
|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ SEXTON, DANIEL J. AND VISWANATHAN, MALINI |
|
| PC | Assignment registered |
Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED Free format text: FORMER OWNER(S): DYAX CORP. |